Xiaohe Luo

6PUBLICATIONS
4CO-AUTHORS
Metabolic medicineMedical infection agents (incl. prions)Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 22, 2026
LY6D promotes hepatic steatosis via the GRB2-AMPK-SREBP1 signaling axis.

|Feb 26, 2025
Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling.

Ting Zeng, Fang Li, Min Yang

|Jul 22, 2024
Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1.

Yao Wu, Min Yang, Shao-Bo Wu

|May 20, 2024
Activation of the PPARγ/NF-κB pathway by A-MPDA@Fe3O4@PVP via scavenging reactive oxygen species to alleviate hepatic ischemia-reperfusion injury.

Dong Mo, Wei Cui, Linxin Chen

|May 23, 2023
Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K/Akt/mTOR signaling pathway.

Qiang Song, Wenjin Zhang, Dan Shi

|Oct 18, 2021
The Antitriple Negative Breast cancer Efficacy of Spatholobus suberectus Dunn on ROS-Induced Noncanonical Inflammasome Pyroptotic Pathway.

Feng Zhang, Qingqing Liu, Kumar Ganesan

Pageof 1

Frequent Collaborators

1 joint publications

Jianping Chen

1 joint publications

Kaiyong Cai

1 joint publications

Jixi Zhang

1 joint publications

Ting Zeng